<DOC>
	<DOC>NCT02992184</DOC>
	<brief_summary>The principal objective is to assess the diagnostic accuracy of the PoC assay (Genedrive, Epistem) to detect HCV RNA against the reference standard of commercial real-time polymerase chain reaction (RT-PCR) assay (RealTime HCV, Abbott) using stored heparinized plasma from patients with chronic hepatitis C and non-infected controls.</brief_summary>
	<brief_title>PoC-HCV Genedrive Viral Detection Assay Validation Study</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Criteria for case Age &gt; 18 years old. Patients with positive HCV RNA. Heparinized plasma samples are available before the initiation of antiviral HCV therapy. Patients have given a written consent that their blood samples will be further used for research. Criteria for control Age &gt; 18 years old. Participants were tested negative for antiHCV antibody Heparinized plasma samples are available Participants have given a written consent that their blood samples will be further used for research</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>HCV</keyword>
	<keyword>Genedrive</keyword>
	<keyword>Point of Care</keyword>
</DOC>